Comparison between the effect of SOX regimen and FOLFOX4 regimen for advanced gastric cancer

Cancer Research and Clinic

Volumn 26, Issue 1, 2014, Pages

  Li, Yuejun ^a   Zhuo, Debin ^a  

^a Hunan Traditional Chinese Medical College   (China)

Author keywords

Antineoplastic combined chemotherapy protocols; Stomach neoplasms

Indexed keywords

FLUOROURACIL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; OXALIPLATIN;

ADVANCED CANCER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DRUG EFFECT; DRUG EFFICACY; HUMAN; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; PERIPHERAL NEUROPATHY; PROGRESSION FREE SURVIVAL; RANDOMIZED CONTROLLED TRIAL; STOMACH CANCER;

EID: 84893324908     PISSN: 10069801     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1006-9801.2014.01.012     Document Type: Article

References (15)

1. Catalano V, Labianca R, Beretta GD. et al. Gastric cancer[J]. Crit Rev Oncol Hematol, 2009, 71: 127-164.
2. Ajani JA, Rodriguez W, Bodoky G, et al. Multicenter phase III comparison ofcisplatin/S-1 with cisplatin/5-FU in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial [J]. J Clino Oncol, 2010, 28: 1547-1553.
3. Ohstu A. Chemotherapy for metastaic gastric cancer past,present and future[J]. J Gastroenterol, 2008, 43: 256-264.
4. Montagnani F, Turrisi G, Marinozzi C, et al. Effectiveness and safety of oxaliplatin compared to cisplatin foradvanced,unresectable gastric cancer: a systematic review and meta-analysis [J]. Gastric Cancer, 2011, 14: 50-55.
5. Oh SY, Kwon HC, Lee S. et al. A Phase JJ. study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignantascites [J]. Jpn J Clin Oncol, 2007, 37: 930-935. (Pubitemid 351176484)
6. Kim HS, Kim JH, Kim HJ, et al. Oxaliplatin, 5-fluorouracil and leucovorin (modifiedFOLFOX-6) as first-line chemotherapy for advanced gastriccancer patients with poor performance status[J]. Oncol Lett, 2012, 3: 425-428.
7. Boku N, Yamamoto S, Fukuda H, et al. Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer:a randomized phase 3 study[J]. Lancet Oncol, 2009, 10: 1063-1069.
8. Koizumi W, Akiya T, Sato A, et al. Phase II study of S-1 as first-line treatment for elderly patients over 75 years of age with advanced gastric cancer: the Tokyo Cooperative Oncology Group study [J]. Cancer Chemother Pharmacol, 2010, 65: 1093-1099.
9. Park I, Lee JL, Ryu MH, et al. Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer[J]. Cancer Chemother Pharmacol, 2010, 65: 473-480.
10. Koizumi W, Takiuchi H, Yamada Y, et al. Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study)[J].Annals of Oncology, 2010, 21: 1001-1005.
11. Liu B, Ying J. Luo et al. S-1 combined with oxaliplatin as first line chemotherapy for Chinese advanced gastric cancer patients [J]. Hepatogastroenterology, 2012, 59: 649-653.